The article describes recent advances in understanding the causes and consequences of microbial translocation in HIV and simian immunodeficiency virus infections.
INTRODUCTION
Simian immunodeficiency virus (SIV) infection of rhesus macaques is the leading model for studying mechanisms of HIV-1 disease progression, recapitulating most of the salient aspects of infection, including viral kinetics, immune dysfunction, and responses to therapeutic interventions [1] . Like other nonhuman primate HIV-1 models, rhesus macaques exhibit a persistent immune activation that is modestly reduced with the initiation of antiretroviral therapy (ART). Although immune activation in treated infection may in part stem from residual antigen presentation [2, 3] , microbial translocation has emerged as a significant contributor.
Microbial translocation broadly describes the passage of microbes or microbial products from the lumen of the gastrointestinal tract into systemic circulation, absent of overt bacterial infection. As first described by Brenchley et al. [4] , microbial translocation was detected through increased levels of plasma lipopolysaccharide (LPS), LPS-binding protein (LBP), and soluble cluster of differentiation 14 (sCD14). In both HIV and SIV infections, LPS levels correlate with a number of immune activation parameters, including monocyte tumor necrosis factor a expression, plasma IFNa, and CD8 þ T-cell activation. In rhesus macaques, treatment with a broad spectrum antibiotic regimen was associated with reduced fecal Gram-negative bacterial loads concomitant with decreased plasma LPS, indicating that the gastrointestinal tract may be the primary source of translocating bacterial products in SIVinfected rhesus macaques and by inference, HIVinfected individuals.
Since this publication, many groups have validated and expanded upon these findings. Here, we will cover recent evidence for and contributors to microbial translocation in lentiviral infections, mechanisms by which translocation contributes to immune activation, and therapeutics aimed at mitigating lingering translocation.
In HIV and SIV infections, microbial translocation has been described predominantly by identifying bacterial products in circulation. Recently, highthroughput sequencing of DNA in circulation has allowed for the identification of systemically disseminated bacterial taxa. In rhesus and cynomolgus macaques (a species of Asian macaques often used for SIV studies), Ericsen et al. [5 && ] observed that plasma 16S rDNA was dramatically elevated during hyperacute SIV macaque (SIVmac) 239 infection. Both before and shortly after infection, translocating bacterial populations in Asian macaques (rhesus macaque and cynomolgus macaque) are composed predominantly of Proteobacteria, with a modest relative expansion throughout infection. In cynomolgus macaques, hyperacute infection is characterized by a rapid increase in plasma levels of Bacteroidetes and Spirochetes at the expense of the remaining phyla. In cynomolgus macaque followed longitudinally, hyperacute expansion is rapidly controlled but falters with the onset of late chronic disease. It is unknown whether plasma 16S rDNA remains elevated in rhesus macaques; however, 16S rDNA recovered from the mesenteric lymph nodes and livers of chronically infected rhesus macaque has previously revealed an enrichment for Proteobacteria, suggesting that the taxa of translocating bacteria remains altered [6] . In HIVinfected patients, sequencing of circulating bacteria products has not been as thorough as in rhesus macaques. Although there are significant increases in 16S rDNA during untreated, chronic infection [7] , a longitudinal analysis is wanting [8, 9] .
The gastrointestinal tract is presumed to be the most significant contributor to microbial translocation, given it has the largest anatomic bacterial load and the extent of damage incurred to the gastrointestinal tract during untreated HIV/SIV infection. Whereas few bacteria are located within the intestinal lamina propria in health, translocating bacteria are increasingly observed postinfection and have been identified as predominantly Proteobacteria in rhesus macaques [6, 10] . In cynomolgus macaques, Ericsen et al. [5 && ] additionally demonstrated that overlap between taxa in the plasma and stool increases after SIV infection. Whether Proteobacterial enrichment among translocating species is preferential or because of an alteration in site of translocation postinfection is unknown [6] . Proteobacterial frequencies are similarly enriched in the oral and respiratory mucosa and though these sites show signs of luminal dysbiosis [11] [12] [13] [14] [15] [16] , a systemic survey for sites of microbial translocation (bacteria and other) has not been executed during HIV or SIV infection. However, a comparison of bacteria from adjacently collected luminal and lamina propriaisolated colonic samples reveals that a preference for Proteobacterial translocation at the intestinal tract is certainly a contributor [6] . A thorough characterization of systemically disseminated microbial products is essential for identifying the origin of these microbes and for designing targeted therapeutics.
MICROBIAL DYSBIOSIS: INSTIGATOR OR BYSTANDER?
Intestinal microbial dysbiosis -an imbalance in the composition of the intestinal microbiome -has been well described in North American HIV-infected patients, with many studies further showing a correlation between expansion of particular bacterial taxa, systemic immune activation, and microbial translocation [17] [18] [19] [20] . These studies broadly describe increases in Proteobacteria at the expense of Firmicutes and particular alterations within the Bacteroidetes phylum with an inversion of Bacteroides spp. to Prevotella spp. ratio. With the acknowledgement that different populations have unique genetic and lifestyle factors, Monaco et al. [21] and Ling et al. [22] recently characterized the fecal microbiome of Ugandan and Chinese cohorts, respectively. In both cohorts, HIV infection was associated with relative increases in Proteobacteria and Firmicutes and declines in Bacteroidetes; however, there were notable differences in subtaxa. Whereas the most significant differences described by Monaco et al. [21] pertained to changes in Bacilli, Gammaproteobacteria, and Actinobacteria taxa, Ling et al. [22] described differences primarily in Bacteroidales, Clostridiales, and Negativicutes, with both groups describing increased Enterobacteriaceae
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The microbiome in HIV postinfection. Only Ling et al. [22] described a significant postinfection difference in Prevotella spp. Monaco et al. [21] further described correlations between several operational taxa units and sCD14, whereas Ling et al. [22] described correlations with proinflammatory cytokines and interleukin (IL)-22.
Intriguingly, evidence for overt microbial dysbiosis in SIV-infected macaques remains scant. As summarized in Table 1 , although we and others have demonstrated a lack of intestinal dysbiosis in macaque cohorts [6, 15, 23] , some have described pointed disruptions [24] [25] [26] . Although intestinal dysbiosis is a known detriment to health, observed dysbiosis in untreated HIV-infected humans may be coincidental or irrelevant, overshadowed by viralmediated pathogenesis. Noguera-Julian et al. [27 && ] demonstrated that stratification by sexual practice removes evidence for infection-associated fecal dysbiosis. In a cohort of over 200 men, the authors demonstrated that MSM displayed a Prevotella spp. and Proteobacteria-enriched enterotype, whereas heterosexual men had a Bacteroides spp.-rich enterotype, independent of infection. Furthermore, although HIV-infected individuals displayed reduced bacterial richness, neither richness nor dysbiosis correlated with microbial translocation or systemic inflammation when sexual preference was considered.
Notwithstanding a role for intestinal bacterial dysbiosis, there is recent evidence for a role of viral dysbiosis in lentiviral disease progression. Building upon a previous report describing an expansion of Adenoviridae in rhesus macaques with advanced AIDS [23] , Handley et al. [26] assessed the fecal metagenome of rhesus macaques vaccinated against SIV and observed that vaccinated-unprotected animals displayed stark increases in Adenoviridae and saploviruses as compared with either unchallenged or vaccine-protected animals. Among animals with gastrointestinal tract complications, there was evidence for significantly increased Enteroviruses spp., Adeonoviridiae, and Adeno-associated virus; however, frequencies of these viruses did not correlate with serum LBP, suggesting that viral dysbiosis is tied to neither bacterial dysbiosis -absent in this study -or translocation. Corroborating these data, Monoco et al. [21] similarly demonstrated that HIVinfected individuals exhibited an expansion of fecal Adenoviridae and Anelloviridae, which correlated with CD4 þ T-cell counts. Although this publication noted that fecal bacterial dysbiosis was evident, no correlations between viral dysbiosis and microbial translocation were noted.
Fecal bacterial populations resemble those isolated from mucosa [18, 20, 21] ; however, the intestinal microbiome shows notable compositional differences longitudinally and cross-sectionally [28, 29] , and it is unlikely that similar microhabitats exist at all mucosal domains. It is worth noting that despite extensive care, intestinal biopsy samples cannot be thoroughly rid of fecal material and thus capture luminal, adherent, and translocating species alike. Disentangling dysbiosis from submucosal microbial translocation (bacterial and other) will require a precise analysis of microbial microhabitats to properly ascribe the effects of dysbiosis on disease progression [30] . þ T cells, they made up 84% of SIV-infected T cells. Supporting previous reports in gastrointestinal tract tissues, Th17 cells in the female reproductive tract did not express higher levels of CCR5 and were not cycling at a higher frequency, leading to uncertainty as to why these cells might be preferentially infected. Following HIV and SIV infection, the epithelial barrier itself releases chemokines that recruit a wave of innate immune cells, including dendritic cells (DC) which form aggregates at the epithelial barrier [42, 43] . As Th17 cells routinely sample antigen from intestinal DCs [44, 45] þ and are incapable of being infected by HIV or SIV. In SIV, depletion of ILCs is most severe in the IL-17-expressing ILC3 subset, with profound decreases observed in both jejunal and colonic tissue [48] . Prolonged depletion in rhesus macaques appears limited to intestinal tissues and is attributable to both increases in ILC3 apoptosis and progressive ILC1 polarization. In contrast, Kloverpris et al. [49] recently demonstrated that HIVinfected patients exhibit circulating -but not intestinal -losses of all ILC subsets throughout infection. In these patients, ILC2s and ILC3s exhibited a downregulation of cell proliferation and viability transcripts limited to acute infection, coupled with increases in CD69 expression. Despite intestinal ILC preservation, circulating ILC levels correlated with plasma levels of intestinal fatty acid-binding protein (released by gastrointestinal tract epithelial cells into circulation upon death), suggesting a relationship with reduced intestinal integrity. Although the mechanisms for ILC loses are still under investigation, it is reasonable to speculate that as with Th17 cells, there may be a role for altered intestinal tryptophan catabolism [17, 24, 50] and the loss of mucosal CD103
þ DCs [51] . Alternatively, the loss of ILCs may instigate Th17 losses by permitting dysregulation among translocating species [24, 52] . The collective loss of IL-17 signaling and damage to the epithelial barrier thus form a self-perpetuating avenue for microbial translocation in progressive SIV infection and likely, HIV-1 infection.
TRANSLOCATION AT THE INTERSECTION OF IMMUNE ACTIVATION
Microbial translocation has emerged as a leading contributor to immune activation in lentiviral disease progression. To be sure, ongoing viral replication plays a role in immune activation; however, in nonprogressor hosts of SIV infection, microbial translocation, and immune activation are restricted to acute infection [53] [54] [55] . Recently, a renewed appreciation for the plasticity of the immune system [56, 57] has led to the consideration that prolonged immune activation and dysfunction may be directly influenced by the taxa of translocating microbes [58] [59] [60] .
Myeloid cell dysregulation has been extensively documented in HIV infection but until recently, focused largely on circulating cell subsets and their potential contributions to lentiviral replication and latency [61, 62] . To broadly assess antimicrobial intestinal innate responses, Glavan et al. [25] measured longitudinally expression of pattern recognition receptors and levels proinflammatory cytokines in the jejunum of SIVmac251-infected rhesus macaques. Here, the authors observed that there was a robust increase in melanoma differentiation-associated protein 5 and toll-like receptor 2, 5, 6, 7, 9, and 10 transcripts during acute infection -increases that exceeded what was seen in the blood -and that these responses dampened with progression into chronic infection.
Hypergammaglobulenemia is common in progressive lentiviral infection. Although this expansion was previously considered nonspecific, translocation may induce a specific antimicrobial humoral response. Hel et al. [63] characterized immunoglobulin responses in both the plasma and intestinal tissues of HIV-infected individuals and observed that while circulating immunoglobulin A (IgA) and IgG concentrations were elevated after infection, IgM showed stark increases in rectal washes. Using a custom protein microarray that included proteins from varied human gut microbes, the authors observed that circulating IgM and IgG from infected patients displayed significantly reduced responses to Proteobacteria and Firmicutes, but not Bacteroidetes antigens. In contrast, rectal IgM responses were significantly elevated against both bacterial and food antigens in infected patients, with variable responsiveness by IgA and IgG. Intriguingly, these authors further observed an inverse correlation between rectal IgA concentrations -both bulk and antimicrobial-and plasma levels of sCD14, suggesting that low intestinal IgA may permit systemic microbial dissemination.
To determine the effect translocating bacteria may have on infected CD4
þ T-cell function, Yoder et al. [64] , used a lamina propria aggregate culture model to infect CD4 þ T cells with an HIV-1 clone in the presence and absence of bacterial exposure. In nonexposed CD4
þ T cells, the authors reported 1000 differentially regulated transcripts and predicted disruption to a number of pathways, including OX40, peroxisome proliferator-activated receptor gamma, and forkhead box O 3. When the authors carried out the same infection in the presence of Prevotella spp., disruptions to these pathways were absent and instead, infection most strongly promoted increases in granzymes and type I interferon stimulated genes. Although the contribution of Prevotella spp. to disease progression remains uncertain [27 && ], this study proposes a useful methodology by which to evaluate the effect of translocating microbes on immune activation.
These studies are part of a larger shift in focus in the HIV field, toward a more holistic assessment of the collective antimicrobial response. A full account of how translocation and lentiviral replication shape each other is necessary for the development of appropriate and durable therapeutics.
THERAPEUTICS
The entwined relationship between the microbiome, epithelial integrity, and intestinal immunity has led researchers to consider that targeting any one of these facets may reduce inflammation in ART-treated HIV-infected individuals. Several recent publications have detailed antimicrobial therapeutics in two categories -those that aim to neutralize circulating microbial products and those that seek to restore the intestinal microbiome.
In both HIV-infected individuals and SIVinfected macaques, antimicrobial therapeutics have shown promising results [65, 66] . Building on the previous observation that phosphate and LPS-binding drug sevelamer reduced immune activation and non-AIDS-related comorbidities in SIV-infected rhesus macaques [66] , Pandrea et al. [67] dually targeted microbial translocation and mucosal inflammation by cotreatment of SIV sabaeus BH 66-infected pigtailed macaque (PTM) with the nonabsorbed antibiotic rifaximin and anti-inflammatory drug sulfasalazine. Treatment during acute infection was associated with lower plasma LPS and sCD14, T-cell activation, markers of hypercoagulation and viremia with subsequent improved mucosal CD4 þ T-cell frequencies. However, these results did not persist into chronic infection, complimenting previous reports suggesting that microbial translocation is only treatable in the presence of ART [65, 66, 68, 69] .
Although the contribution of dysbiosis to untreated disease progression remains contentious, probiotic administration to ART-treated HIVinfected individuals [69] and SIV-infected macaques [68] demonstrates a clear immunological benefit. Considering a report demonstrating that ART and IL-21 cotreatment improved intestinal Th17 recovery independent of improved translocation [70] , Ortiz et al. [71 & ] recently demonstrated that combining ART, probiotics, and IL-21 enhanced immune reconstitution and lowered microbial translocation in SIVmac239-infected PTMs. The mechanisms for reduced translocation in this trivalent approach remain unknown; however, the synergistic benefits of this regimen may indicate that a basal threshold of stasis (viral suppression, commensal restoration, and Th17 presence) is required to sustain physical and immunological mucosal repair.
Fecal microbial transplantation (FMT) has been proposed as an added treatment for ART-treated, HIV-infected individuals. FMT has the benefit of introducing a presumably balanced microbiome, including undercharacterized microbes with essential roles [72] . To address the feasibility of this treatment for HIV-infected individuals, HensleyMcBain et al. [73 & ] gave SIVmac239-infected, ARTtreated macaques antibiotics followed by FMT from donor-uninfected macaques. Here, antibiotics were used to clear the host microbiome [74] . Successful engraftment of the donor microbiome led to significant improvements in peripheral Th17 and Th22 compared to pre-FMT, as well as decreased intestinal T-cell activation. No increases in circulating LBP or IL-6R were noted; however, there were persistent increases in sCD14 out to 6 weeks post-FMT, indicating that microbial translocation per se does not preclude immune reconstitution. Vujkovic-Cvijin et al. [75] similarly attempted FMT in ART treated, HIV-infected individuals but here, in the absence of antibiotic pretreatment. Although FMT was well tolerated, no changes in inflammatory profiles were noted and an examination of the host fecal microbiome revealed only partial engraftment. These studies indicate that although FMT may serve a potential immunological benefit, extensive studies are needed to tailor this treatment to HIVinfected individuals.
CONCLUSION
Microbial translocation remains a strong contributor to inflammation in both untreated and treated lentiviral infections. The identification of translocating species in SIV-infected rhesus macaques has revealed an enrichment for Proteobacteria [5 && ,6 ] and led to a realization that specific deficits in antimicrobial immunity likely contribute to translocation and subsequently, disease progression. The continued, detailed categorization of translocating species at potential sites of transmission is necessary for the identification of the most immunostimmulatory moieties. The encouraging results of probiotic and FMT as ART adjuncts highlight the benefits of antimicrobial therapy in treated lentiviral infections and suggest that targeted antimicrobials may further improve immune reconstitution in infected patients.
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